Kodiak Sciences (KOD) Financials

$35.59

$-0.77 (-2.12%)

As on 04-Sep-2026 13:38EDT

Market cap

$2,371 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

40.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	-6.93	--	26.71	25.95	11.00	8.71
Gross Profit	6.93	--	-26.71	-25.95	-11.00	-8.71
Operating Expenses	246.42	234.39	160.14	251.37	330.38	258.34
Operating Profit (EBIT)	-246.42	-234.39	-186.85	-277.32	-341.38	-267.05
Other Income	--	--	--	--	7.57	0.08
Profit before Tax	-241.99	-229.97	-176.21	-260.49	-333.82	-266.99
Provision for Tax	--	--	--	--	7.35	-0.15
Profit after Tax (Net Income)	-241.99	-229.97	-176.21	-260.49	-333.82	-266.99
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-333.82	-266.99

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	61.10	157.38	150.29	265.78	436.17	663.32
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	142.95	148.62	159.72	171.86	177.97	176.22
Current Liabilities	52.77	45.53	25.57	41.73	52.50	64.68
Total Liabilities	309.58	351.53	335.58	479.37	666.63	904.22

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	125.45	136.72	163.64	190.06	180.62	169.41
Current Assets	131.36	214.82	171.94	289.31	486.01	734.81
Total Assets	388.17	351.53	335.58	479.37	666.63	904.22
Total Debt*	95.70	159.18	70.35	181.63	187.73	179.94
Net Current Assets	--	169.28	146.36	247.58	433.51	670.13

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-136.01	-117.32	-154.18	-206.46	-182.27
Cash Flow from Investing Activities	--	-0.51	-0.76	249.23	-336.51	-38.80
Cash from Financing Activities	--	178.30	0.50	0.03	1.90	8.18
Net Cash Inflow / Outflow	--	--	--	--	-541.08	-212.89

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-4.22	-4.32	-3.35	-4.96	-6.38	-5.14
Cash EPS ($)	--	-3.83	-2.84	-4.47	-6.17	-4.97
Adjusted Book Value ($)	--	2.96	2.85	5.06	8.34	12.76
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.56	-2.23	-2.94	-3.95	-3.51
Free Cash Flow per Share ($)	--	-2.57	-2.24	-3.73	-4.85	-4.72

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-85.62	-52.75	-48.63	-45.51	-29.98
ROE (%)	-221.53	-149.49	-84.70	-74.22	-60.72	-35.04
ROA (%)	-71.61	-66.94	-43.24	-45.46	-42.50	-27.08
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-4,407.49	-321,674.70
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	13.60	-30.51	32.35	21.97	-25.04	-100.62
Net Profit Growth (%)	-21.10	-30.51	32.36	21.97	-25.03	-100.60
EPS Growth (%)	-11.23	-0.29	0.33	0.22	-0.24	-0.85
Book Value Growth (%)	-26.75	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-6.47	-2.97	-0.61	-1.12	-16.51
Price / Book Value	40.18	9.45	3.49	0.60	0.86	6.64
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.12	-7.06	-2.85	-0.24	-0.26	-14.93
Close Price ($)	38.96	27.96	9.95	3.04	7.16	84.78
High Price ($)	47.84	31.18	11.60	9.80	90.24	171.21
Low Price ($)	3.60	1.92	2.19	1.37	4.90	73.19
Market Cap ($ Cr)	2,370.68	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	1.01	0.47	0.68	0.43	0.27
Short term debt to equity ratio	0.16	0.08	0.07	0.04	0.02	0.01
Current Ratio	2.49	4.72	6.72	6.93	9.26	11.36
Quick Ratio	2.49	--	--	--	--	--
Interest Coverage	--	--	--	-20,036.77	-18,544.72	-12,134.91

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	119.83	160.04	357.93	441.88
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.